SOLIGENIX, INC.

SNGX · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.0B · 14 employees
337
SEC Filings
$0.3848
Close 2026-07-06
14
Employees

Business Summary

Soligenix, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing products for rare diseases with unmet medical needs. It operates two segments: Specialized BioTherapeutics (HyBryte for CTCL, SGX302 for psoriasis, dusquetide for Behcet's Disease and oral mucositis) and Public Health Solutions (RiVax ricin vaccine, SGX943 for infectious disease, filovirus vaccines, CiVax for COVID-19), leveraging its proprietary ThermoVax heat stabilization platform with government funding support.

Latest Stock Quote

SNGX 2026-07-06 $0.3848 O:$0.39 H:$0.3977 L:$0.382 Vol:0.5M VWAP:$0.3862
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-09-19

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-312025-12-310001104659-26-037701EDGAR75K words
2025-03-212024-12-310001558370-25-003459EDGAR—
2024-03-152023-12-310001558370-24-003402EDGAR—
2023-03-312022-12-310001558370-23-005304EDGAR—
2022-03-292021-12-310001558370-22-004605EDGAR—
2021-03-302020-12-310001213900-21-018698EDGAR—
2020-03-302019-12-310001213900-20-007959EDGAR—
2019-03-262018-12-310001213900-19-004865EDGAR—
2018-03-152017-12-310001213900-18-003007EDGAR—
2017-03-272016-12-310001213900-17-002845EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-072026-06-300001104659-26-092681EDGAR—
2025-11-072025-09-300001104659-25-108475EDGAR30K words
2025-08-142025-06-300001558370-25-011554EDGAR—
2025-05-092025-03-310001558370-25-007171EDGAR—
2024-11-082024-09-300001558370-24-015054EDGAR—
2024-08-092024-06-300001558370-24-011740EDGAR—
2024-05-102024-03-310001558370-24-007782EDGAR—
2023-11-132023-09-300001558370-23-018818EDGAR—
2023-08-212023-06-300001558370-23-015144EDGAR—
2023-05-152023-03-310001558370-23-009929EDGAR—
2022-11-102022-09-300001558370-22-017406EDGAR—
2022-08-122022-06-300001558370-22-013491EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-120001104659-26-014267EDGAR1K words
2026-01-230001104659-26-006233EDGAR—
2025-11-180001104659-25-113645EDGAR—
2025-09-290001104659-25-094507EDGAR—
2025-08-180001558370-25-011625EDGAR—
2025-08-150001558370-25-011619EDGAR—
2025-07-310001104659-25-072708EDGAR—
2025-06-200001558370-25-008772EDGAR—
2025-03-280001558370-25-003987EDGAR—
2025-02-100001558370-25-000726EDGAR—

337 total filings indexed. 305 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

rare-diseases cutaneous-t-cell-lymphoma psoriasis infectious-diseases-and-biodefense oncology-supportive-care public-health-vaccines photodynamic-therapy-(pdt)-using-visible-fluorescent-light innate-defense-regulator-(idr)-technology thermovax-heat-stabilization-platform cails-(composite-assessment-of-index-lesion-disease-severity)-scoring

Company Identity

CIK0000812796
TickerSNGX
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
HeadquartersPrinceton, New Jersey
Websitehttps://www.soligenix.com
Listed1994-04-05

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: ad91084fb3b3333acb1bb0c83089babc30da143df1d79c22eeedc18fe07f3ca7
parent: 7942cf9abe1e5407ad07bb073e024fe66d5351eab8df70e04323f7dbc9fd1a96
content hash: 319ad8f7c134ad813542b101732e84293adef62a6b486e1d173d1509d2b31295
signed: 2026-08-12T19:05:32.128Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up SNGX using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on SNGX, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/SNGX (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.